Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Ebglyss

Australian Public Assessment Report

AusPAR

AusPAR Ebglyss [PDF, 2.64 MB]

AusPAR Ebglyss [DOCX, 8.24 MB]

Attachment Product Information for Ebglyss [PDF, 427.28 KB]

Attachment Product Information for Ebglyss [DOCX, 334.36 KB]

Device/Product Name

Ebglyss

Active ingredients

Lebrikizumab

AusPAR Date

8 October 2024

Published

22 October 2024

Submission Number

PM-2023-01192-1-1

Submission Type

New biological medicine

Decision

Approved

Product types

Prescription medicines